T. Nomura et al., NITRIC-OXIDE DONOR NOR-3 INHIBITS KETOGENESIS FROM OLEATE IN ISOLATEDRAT HEPATOCYTES BY A CYCLIC GMP-INDEPENDENT MECHANISM, Pharmacology & toxicology, 82(1), 1998, pp. 40-46
Studies were conducted to clarify the effects of nitric oxide donors N
OR 3 -ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexeneamide, FK409), SIN-1
(3-morpholinosydnonimine) and SNAP (S-nitroso-N-acetylpenicillamine) o
n the accumulation of cGMP and cAMP and Ca2+ mobilization as well as k
etogenesis from oleate in isolated rat hepatocytes. NOR 3 caused inhib
ition of ketogenesis from oleate along with stimulation of cGMP accumu
lation in rat hepatocytes, whereas SIN-1 and SNAP exerted no effect on
ketogenesis despite their marked stimulation of cGMP accumulation. Al
though the nitric oxide frapping agent, carboxy-PTIO (2-phenyl-4,4,5,5
-tetramethylimidazoline-1-oxyl 3-oxide), antagonized the stimulation b
y NOR 3 of cGMP accumulation, it failed to modulate the anti-ketogenic
action of NOR 3. Furthermore, neither 8-bromoguanosine-3',5'-cyclic m
onophosphate nor N-2,2'-O-dibutyrylguanosine-3',5'-cyclic monophosphat
e mimicked the anti-ketogenic action of NOR 3. It is concluded in the
present study that NOR 3-induced inhibition of ketogenesis in rat hepa
tocytes is not mediated by cGMP. The present study revealed that the r
emaining structure of NOR 3 from which nitric oxide had been spontaneo
usly released had no anti-ketogenic action. We first and clearly demon
strated that nitrite production was dramatically enhanced when NOR 3 w
as incubated in the presence of rat hepatocytes. The mechanism whereby
NOR 3 inhibits ketogenesis in rat hepatocytes will be discussed.